Skip to content
Open access

Region-specific cerebral blood flow differentiates cognitively impaired and unimpaired individuals with core Alzheimer's disease pathology

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

MRI measures of cerebral blood flow and white matter hyperintensities differentiated NDAN from AD+MCI, highlighting vascular contributions to cognitive resilience, and CBF differentiated AD+MCI from Controls.

Read PDF

Similar papers

Open access Aug 2026

White Matter and Perivascular Imaging Changes in Alzheimer's Disease and Cerebral Amyloid Angiopathy

Global and occipital PSMD may help identify AD participants with concomitant cerebral amyloid angiopathy (CAA) and DTI‐ALPS indices were associated with preserved language function and memory, and no PSMD metric was associated with any clinical measure.

Debina Laishram, G. Du, Sangam Kanekar et al. · 0 citations
Open access Sep 2026

Gray matter atrophy mediates the association between cerebral hypometabolism and cognitive impairment in Alzheimer’s disease

Objective Alzheimer’s disease (AD) is characterized by amyloid deposition, brain hypometabolism, gray matter atrophy and cognitive decline, yet their causal interactions are poorly defined. This multimodal PET/MRI study explored regional gray matter volume (GMV) loss and glucose hypometabolism in AD patients, and clari...

Shi-Qi Zhao, Jian-Wen Chen, Pei-Xue Li et al. · 0 citations
Open access Sep 2026

White matter microstructure and motor function in amnestic mild cognitive impairment and Alzheimer's dementia

White matter SC is affected in AD, particularly in medial temporal lobe regions that are known to be affected early in the disease, particularly in medial temporal lobe regions that are known to be affected early in the disease.

Sarah E. Cote, M. Ruitenberg, J. N. van der Geest et al. · 0 citations
Sep 2026

Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study.

OBJECTIVE Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer's disease (AD), with significant pathological overlap between the two conditions. However, the impact of Alzheimer's co-pathology on basal forebrain (BF) atrophy and its relationship with neurodegeneration and...

Daniele Urso, Thomas Giannelli, B. Tafuri et al. · 0 citations
Open access Aug 2026

Magnetic Resonance Imaging-Based Cortical and Subcortical Volumetric Changes in Alzheimer’s Disease: Association with Clinical Severity

Automated MRI volumetry may support the quantitative assessment of neurodegeneration in clinically defined AD and MCI, although these findings require external validation in larger, longitudinal, biomarker-characterized cohorts.

A. Alagoz, Serap Ozturk, S. D. Bunul et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.